Drug-Eluting Balloons Versus Everolimus-Eluting Stents for In-Stent Restenosis: A Meta-Analysis of Randomized Trials-Reference-Cited by-同舟云学术

Drug-Eluting Balloons Versus Everolimus-Eluting Stents for In-Stent Restenosis: A Meta-Analysis of Randomized Trials

Published:2019-07 Issue:7 Volume:20 Page:612-618
ISSN:1553-8389
Container-title:Cardiovascular Revascularization Medicine
language:en
Short-container-title:Cardiovascular Revascularization Medicine

Author:

Elgendy Islam Y.,Mahmoud Ahmed N.,Elgendy Akram Y.,Mojadidi Mohammad K.,Elbadawi Ayman,Eshtehardi Parham,Pérez-Vizcayno María José,Wayangankar Siddharth A.,Jneid Hani,David Anderson R.,Alfonso Fernando

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference48 articles.

1. Drug-eluting coronary-artery stents;Stefanini;N Engl J Med,2013

2. Routine invasive versus selective invasive strategies for non-ST-elevation acute coronary syndromes: an updated meta-analysis of randomized trials;Elgendy;Catheter Cardiovasc Interv,2016

3. Current treatment of in-stent restenosis;Alfonso;J Am Coll Cardiol,2014

4. In-stent restenosis in the drug-eluting stent era;Dangas;J Am Coll Cardiol,2010

5. Long-term safety of drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis;Palmerini;J Am Coll Cardiol,2015

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of chronic coronary syndromes;European Heart Journal;2024-08-30

2. Outcomes With Limus- vs Paclitaxel-Coated Balloons for Percutaneous Coronary Intervention;JACC: Cardiovascular Interventions;2024-07

3. Outcomes of Percutaneous Coronary Intervention for In‐Stent Restenosis Versus De Novo Lesions: A Meta‐Analysis;Journal of the American Heart Association;2023-07-04

4. Incidence and predictors of recurrent in-stent restenosis after drug-coated balloon angioplasty from central China;2023-01-10

5. Rapamycin and Paclitaxel Affect Human Aortic Smooth Muscle Cells-Derived Foam Cells Viability and Proliferation;Brazilian Journal of Cardiovascular Surgery;2022